The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease

Journal of Cardiovascular Magnetic Resonance

Volumn 13, Issue 1, 2011, Pages

  Gebker, Rolf ^a   Jahnke, Cosima ^b   Manka, Robert ^a   Hucko, Thomas ^a   Schnackenburg, Bernhard ^c   Kelle, Sebastian ^a   Klein, Christoph ^a   Fleck, Eckart ^a   Paetsch, Ingo ^b  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c PHILIPS HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; CARDIOTONIC AGENT; CARDIOVASCULAR AGENT; DIAGNOSTIC AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL DECISION MAKING; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOBUTAMINE STRESS CARDIOVASCULAR MAGNETIC RESONANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOLOGIC STRESS TESTING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; AGED; CHI SQUARE DISTRIBUTION; DISEASE COURSE; DISEASE FREE SURVIVAL; EVALUATION; GERMANY; KAPLAN MEIER METHOD; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME;

AGED; CARDIOTONIC AGENTS; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOBUTAMINE; FEMALE; GERMANY; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84855171803     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-13-46     Document Type: Article

References (32)

1. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Gibbons RJ, Alpert JS, Antman EM, Hiratzka LF, Fuster V, Faxon DP, Gregoratos G, Jacobs AK, Smith SC Jr, Circulation 2003 107 149 158 10.1161/01.CIR.0000047041. 66447.29 12515758 (Pubitemid 36070948)
2. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. Hendel RC, Patel MR, Kramer CM, Poon M, Hendel RC, Carr JC, Gerstad NA, Gillam LD, Hodgson JM, Kim RJ, Kramer CM, Lesser JR, Martin ET, Messer JV, Redberg RF, Rubin GD, Rumsfeld JS, Taylor AJ, Weigold WG, Woodard PK, Brindis RG, Hendel RC, Douglas PS, Peterson ED, Wolk MJ, Allen JM, Patel MR, J Am Coll Cardiol 2006 48 1475 1497 10.1016/j.jacc.2006.07.003 17010819
3. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, Weintraub WS, O'Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J, Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ, Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK, Boden WE, Circulation 2008 117 1283 1291 10.1161/CIRCULATIONAHA.107.743963 18268144 (Pubitemid 351365675)
4. Additional Value of Myocardial Perfusion Imaging During Dobutamine Stress Magnetic Resonance for the Assessment of Coronary Artery Disease. Gebker R, Jahnke C, Manka R, Hamdan A, Schnackenburg B, Fleck E, Paetsch I, Circ Cardiovasc Imaging 2008 1 122 130 10.1161/CIRCIMAGING.108.779108 19808529
5. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Hundley WG, Hamilton CA, Thomas MS, Herrington DM, Salido TB, Kitzman DW, Little WC, Link KM, Circulation 1999 100 1697 1702 10525488 (Pubitemid 29485251)
6. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E, Ellmer A, Dreysse S, Fleck E, Circulation 1999 99 763 770 9989961 (Pubitemid 29083016)
7. Current clinical applications of stress wall motion analysis with cardiac magnetic resonance imaging. Paetsch I, Jahnke C, Fleck E, Nagel E, Eur J Echocardiogr 2005 6 317 326 10.1016/j.euje.2004.12.008 16112912 (Pubitemid 41258923)
8. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, van Rossum AC, Shaw LJ, Yucel EK, J Cardiovasc Magn Reson 2004 6 727 765 10.1081/JCMR-200038581 15646878 (Pubitemid 40041279)
9. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases. Wahl A, Paetsch I, Gollesch A, Roethemeyer S, Foell D, Gebker R, Langreck H, Klein C, Fleck E, Nagel E, Eur Heart J 2004 25 1230 1236 10.1016/j.ehj.2003.11.018 15246641 (Pubitemid 38891573)
10. Magnetic resonance imaging determination of cardiac prognosis. Hundley WG, Morgan TM, Neagle CM, Hamilton CA, Rerkpattanapipat P, Link KM, Circulation 2002 106 2328 2333 10.1161/01.CIR.0000036017.46437.02 12403662 (Pubitemid 35244733)
11. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Jahnke C, Nagel E, Gebker R, Kokocinski T, Kelle S, Manka R, Fleck E, Paetsch I, Circulation 2007 115 1769 1776 10.1161/CIRCULATIONAHA.106.652016 17353441 (Pubitemid 46648614)
12. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC, J Am Coll Cardiol 2007 50 1343 1353 10.1016/j.jacc.2007.06.030 17903634 (Pubitemid 47449733)
13. Prediction of coronary heart disease using risk factor categories. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB, Circulation 1998 97 1837 1847 9603539 (Pubitemid 28213628)
14. Stress cardiovascular magnetic resonance: consensus panel report. Nagel E, Lorenz C, Baer F, Hundley WG, Wilke N, Neubauer S, Sechtem U, van der Wall E, Pettigrew R, de Roos A, Fleck E, van Rossum A, Pennell DJ, Wickline S, J Cardiovasc Magn Reson 2001 3 267 281 10.1081/JCMR-100107475 11816623 (Pubitemid 33062631)
15. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, Circulation 2002 105 539 542 10.1161/hc0402.102975 11815441 (Pubitemid 34262671)
16. Improved accuracy of quantitative assessment of left ventricular volume and ejection fraction by geometric models with steady-state free precession. Thiele H, Paetsch I, Schnackenburg B, Bornstedt A, Grebe O, Wellnhofer E, Schuler G, Fleck E, Nagel E, J Cardiovasc Magn Reson 2002 4 327 339 10.1081/JCMR-120013298 12234104 (Pubitemid 34983286)
17. The electrocardiographic exercise test in a population with reduced workup bias: diagnostic performance, computerized interpretation, and multivariable prediction. Veterans Affairs Cooperative Study in Health Services #016 (QUEXTA) Study Group. Quantitative Exercise Testing and Angiography. Froelicher VF, Lehmann KG, Thomas R, Goldman S, Morrison D, Edson R, Lavori P, Myers J, Dennis C, Shabetai R, Do D, Froning J, Ann Intern Med 1998 128 965 974 9625682
18. Prediction of cardiac events in patients with reduced left ventricular ejection fraction with dobutamine cardiovascular magnetic resonance assessment of wall motion score index. Dall'Armellina E, Morgan TM, Mandapaka S, Ntim W, Carr JJ, Hamilton CA, Hoyle J, Clark H, Clark P, Link KM, Case D, Hundley WG, J Am Coll Cardiol 2008 52 279 286 10.1016/j.jacc.2008.04.025 18634983 (Pubitemid 351957860)
19. Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion. Korosoglou G, Elhmidi Y, Steen H, Schellberg D, Riedle N, Ahrens J, Lehrke S, Merten C, Lossnitzer D, Radeleff J, Zugck C, Giannitsis E, Katus HA, J Am Coll Cardiol 56 1225 1234
20. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. Geleijnse ML, Fioretti PM, Roelandt JR, J Am Coll Cardiol 1997 30 595 606 10.1016/S0735-1097(97)00206-4 9283514 (Pubitemid 27397635)
21. Optimal medical therapy with or without PCI for stable coronary disease. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS, N Engl J Med 2007 356 1503 1516 10.1056/NEJMoa070829 17387127 (Pubitemid 46588415)
22. A randomized trial of therapies for type 2 diabetes and coronary artery disease. Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE, N Engl J Med 2009 360 2503 2515 19502645
23. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Chaitman BR, Hardison RM, Adler D, Gebhart S, Grogan M, Ocampo S, Sopko G, Ramires JA, Schneider D, Frye RL, Circulation 2009 120 2529 2540 10.1161/CIRCULATIONAHA.109.913111 19920001
24. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS, Circulation 2003 107 2900 2907 10.1161/01.CIR.0000072790.23090.41 12771008 (Pubitemid 36736630)
25. Prediction of mortality using dobutamine echocardiography. Marwick TH, Case C, Sawada S, Rimmerman C, Brenneman P, Kovacs R, Short L, Lauer M, J Am Coll Cardiol 2001 37 754 760 10.1016/S0735-1097(00)01191-8 11693748 (Pubitemid 32202441)
26. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Beller GA, Zaret BL, Circulation 2000 101 1465 1478 10736294 (Pubitemid 30169872)
27. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM, J Am Coll Cardiol 2003 42 954 970 10.1016/S0735-1097(03)01065-9 12957449 (Pubitemid 37069224)
28. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T, Passamani E, Norris R, et al. Lancet 1994 344 563 570 10.1016/S0140-6736(94)91963-1 7914958 (Pubitemid 24267213)
29. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients. McCully RB, Roger VL, Mahoney DW, Karon BL, Oh JK, Miller FA, Seward JB, Pellikka PA, J Am Coll Cardiol 1998 31 144 149 9426033 (Pubitemid 28064735)
30. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Cheong BY, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S, Elayda MA, Lee VV, Flamm SD, Circulation 2009 120 2069 2076 10.1161/CIRCULATIONAHA.109.852517 19901193
31. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, Di Carli MF, Reynolds HG, Stevenson WG, Kwong RY, Circulation 2006 114 32 39 10.1161/CIRCULATIONAHA.106.613414 16801462 (Pubitemid 44305272)
32. Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Steel K, Broderick R, Gandla V, Larose E, Resnic F, Jerosch-Herold M, Brown KA, Kwong RY, Circulation 2009 120 1390 1400 10.1161/CIRCULATIONAHA.108.812503 19770399